Technology

USA Based CIPRA.ai Expands its Precision Chronic Care Services to India, Partners with RxDx, 2050 Healthcare, and ARTPARK @IISc Bangalore

Published

2 years ago

February 15, 2024

CIPRA.ai has launched its health services in India to help patients combat chronic conditions through personalized and proactive care. The health technology platform has formed partnerships with two leading healthcare players in India – RxDx and 2050 Healthcare and one innovation partner, ARTPARK @IISc Bangalore, to revolutionize the approach to manage and improve chronic care in India.

SAN FRANCISCO, Feb. 15, 2024 /PRNewswire-PRWeb/ — San Diego, California based leading health technology platform CIPRA.ai has announced the launch of its personalized services in India and a strategic partnership with renowned healthcare providers in the industry – RxDx and 2050 Healthcare and innovation partner ARTPARK @IISc Bangalore. The Bengaluru based RxDx, a NABH and NABL-accredited multispeciality healthcare chain, and 2050 Healthcare, a leading healthcare provider specializing in rehabilitation and home healthcare, will help CIPRA.ai expand its presence in India. ARTPARK @IISc Bangalore, a leading AI and robotics accelerator backed by the Indian Institute of Science, has become CIPRA.ai’s innovation partner to help it scale growth objectives and achieve its first 10K patients by 2024. The primary goal of the partnership is to help address gaps in conventional care and capacitate patients and physicians to control and reverse chronic diseases using AI and data-driven precision care in India. Through collective efforts, CIPRA.ai also aims to become a health tool that enables healthcare providers to expand clinical capacities.

CIPRA services in India will revolutionize how patients and the medical community approach treatment. This commercial partnership will deliver improved patient outcomes and enhance the Indian healthcare system, a win-win scenario for everyone.

CIPRA.ai’s subscription services are designed to offer precise and personalized patient care treating and reversing chronic conditions such as diabetes and hypertension. According to WHO, in India, nearly 77 million individuals suffer from type 2 diabetes, and 25 million are at a high risk of developing the condition in the future. On the other hand, only 12% of individuals with hypertension have their blood pressure under control. By developing individualized AI models from data collected via wearables and monitoring devices, the platform identifies the root cause of chronic diseases and guides patients to manage their conditions. CIPRA.ai’s autonomous AI-based interactions and simple solutions have led to 90% patient engagement and a 5X decrease in the chronic population in the US. Through the new strategic partnerships, CIPRA.ai will replicate its success in India. . It also aims to help healthcare partners enhance patient care and offer more accurate solutions without upending the heterogeneous lifestyle of Indian patients.

CEO and Founder of CIPRA.ai, Dr. Sujit Dey, expressed his thoughts on the new exciting developments, stating, “At CIPRA.ai, we aim to improve personalized care delivery for patients as we understand that effective diagnosis and treatment for chronic conditions is not a one-size-fits-all solution. With the launch of our services in India, we will revolutionize how patients and the medical community approach treatment. We are confident CIPRA.ai’s commercial partnership with RxDx, and 2050 Healthcare with the support of ARTPARK @IISc Bangalore will help us navigate this shift to deliver improved patient outcomes and enhance the Indian healthcare system, a win-win scenario for everyone.”

Before launching services in India, CIPRA.ai has been successfully delivering hypertension and diabetes services in the USA since 2022. The healthtech platform is seeking meaningful partnerships with clinics and hospitals to enhance its presence in India and strengthen its position in the healthcare domain. CIPRA.ai plans to expand its focus beyond hypertension and diabetes to offer data-based precision care to more chronic diseases.

About CIPRA.ai

CIPRA.ai is the accumulation of eight years of R&D and clinical trials at UC San Diego – supported by Kaiser Permanente, UC San Diego Population Health, Altman Clinical Translational Research Institute, Samsung, Teradata and other industry leaders – which focused on using AI to precisely diagnose and treat patients with chronic conditions. The impetus for this work came from CIPRA.ai’s founder Sujit Dey, after a series of self-experiments determined that sleep was the greatest contributor to his hypertension. These findings motivated Sujit to develop a data-driven, intelligent solution to untangle the complex relationships between lifestyle and chronic conditions, as he was joined by former PhD students and co-founders Jared Leitner and PoHan Chiang. Assembling a distinguished team of physicians and experts, the company was launched in July of 2022 and has expanded its AI-based platform to cover chronic hypertension and diabetes, reaching global influence through health system partnerships around the world.

At the core of CIPRA.ai is an understanding that healthcare is not a one-size-fits-all solution. Managing chronic conditions on your own can be burdensome and disorienting with a series of trial and error, or dealing with varying opinions from different people. That is why the CIPRA.ai platform was built with a simple mission – to provide precise care for chronic hypertension and diabetes, so each patient can focus on the right actions for improving their health with ease and clarity.

Contact: info@cipra.ai

Media Contact

Antoripa Dey, CIPRA.ai, 1 858-722-7554, info@cipra.ai, www.CIPRA.ai

View original content to download multimedia:https://www.prweb.com/releases/usa-based-cipraai-expands-its-precision-chronic-care-services-to-india-partners-with-rxdx-2050-healthcare-and-artpark-iisc-bangalore-302061827.html

SOURCE CIPRA.ai

Technology

Equifax Announces Participation in Upcoming Investor Conferences

Published

57 minutes ago

May 1, 2026

ATLANTA, May 1, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) will participate in several upcoming investor conferences in May and June.

Mark W. Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the Baird 2026 Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 including participation in a Fireside Chat at 10:50 a.m., Eastern Time and the William Blair 2026 Growth Stock Conference on Wednesday, June 3, 2026, including participation in a Fireside Chat at 9:40 a.m., Eastern Time.

The company invites investors to join a live webcast of these Fireside Chat events at: https://investor.equifax.com/news-events/ir-calendar. A replay of these Fireside Chats will be available within 24 hours after the event on the company’s Investor Relations website.

John Gamble, Chief Financial Officer, will attend the Bernstein Annual Strategic Decisions Conference on Wednesday, May 27, 2026.

Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the Barclays Americas Select Franchise Conference on Tuesday, May 5, 2026, the virtual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, and the J.P. Morgan All Stars Canada Conference on Tuesday, June 2, 2026.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Molly Clegg for Equifax
mediainquiries@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-participation-in-upcoming-investor-conferences-302760292.html

SOURCE Equifax Inc.

Technology

Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results

Published

57 minutes ago

May 1, 2026

SAN JOSE, Calif., May 1, 2026 /PRNewswire/ — Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results for the period ending Saturday, April 25, 2026.

Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, May 13, 2026. Cisco’s quarterly earnings press release will be posted at https://newsroom.cisco.com.

Date:
Wednesday, May 13, 2026

Time:
1:30 PM (PT); 4:30 PM (ET)

To Listen via Telephone:
888-848-6507
212-519-0847 (for International Callers)

To Listen via the Internet:
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at https://investor.cisco.com.

The conference call will also be livestreamed on YouTube & LinkedIn.

Replay:
A telephone playback of the Q3 FY2026 conference call is scheduled to be available beginning at 4:00 PM (PT) on May 13, 2026, through 10:00 PM (PT) May 19, 2026. The replay will be accessible by calling 800-839-2232 (International callers: 203-369-3662). The call runs 24 hours/day, including weekends. An archived version of the webcast will be available on Cisco’s Investor Relations website at https://investor.cisco.com.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

Investor Relations Contact:

Press Contact:

Sami Badri

Britt Stagnaro

Cisco

sambadri@cisco.com

media_pr@external.cisco.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-schedules-conference-call-for-q3-fiscal-year-2026-financial-results-302760253.html

SOURCE Cisco Systems, Inc.

Technology

Essen Health Care Launches RADIN Health All-In-One RIS and PACS Cloud Platform

Published

57 minutes ago

May 1, 2026

SHERIDAN, Wyo. , May 1, 2026 /PRNewswire/ — Essen Health Care is thrilled to announce a significant advancement in our commitment to providing exceptional patient care and cutting-edge medical services: the introduction of RADIN Health.

This initiative represents a major investment in the future of medical imaging, solidifying our dedication to offering the highest quality diagnostic services and an unparalleled patient and provider experience within the communities we serve.

“RADIN Health is more than just a technology upgrade; it is a fundamental pillar of Essen Health Care’s strategy to deliver accessible, efficient, and superior diagnostic imaging services to our community”, says Jonathan Khodadadian, MD, Medical Director, Specialty Division, Essen Health Care.

The RADIN Platform: A Commitment to Innovation

RADIN Health is powered by an advanced, end-to-end, all-in-one RIS and PACS radiology cloud platform. This state-of-the-art system has been meticulously designed to revolutionize the imaging process, ensuring efficiency, accuracy, and accessibility for everyone involved.

Transforming the Patient and Provider Journey

The RADIN platform utilizes sophisticated, state-of-the-art artificial intelligence (AI) across multiple facets of the imaging journey:

Enhanced Patient and Provider Engagement: AI tools, patient, and referring physician portals streamline orders for appointments and communication, ensuring the external workflow process is easy, transparent, and accessible.Easy Image and Report Sharing: The cloud application allows easy electronic sharing and access of images and reports for providers and patients.Ease of Scheduling: The system simplifies the typically complex scheduling process, allowing for quick, convenient, and accurate appointment booking.Optimized Physician Reporting: AI assists in the generation of detailed, rapid, and precise physician reports, ensuring healthcare providers receive the critical information they need promptly to guide treatment decisions.

Driving Efficiency and Quality

The RADIN platform elevates the operational standards of imaging services. By reducing manual steps throughout the process—from order entry to image archival—and improving overall system efficiency, the platform ensures:

Timely Imaging Services: Quicker turnaround times mean patients receive their diagnoses faster, enabling earlier treatment planning.High-Quality Diagnostics: The system supports consistent, high-fidelity imaging quality, leading to more accurate diagnoses.Patient Follow-up Tracking: Recommended patient follow-up scans are automated and track recommendations for important, abnormal or inconclusive findings.Compliance and Best Practices: The cloud platform is built to support stringent regulatory compliance and adherence to the highest industry standards and best practices, giving both providers and patients confidence in the care received.

Essen Health Care is an integrated, multi-specialty healthcare delivery organization with more than 25 years of experience providing quality, compassionate, and accessible medical care to communities across New York. Offering house calls, urgent care, primary care, and specialty services, Essen Health Care is committed to advancing health equity and improving health outcomes for all patients. For more information, visit https://www.essenhealthcare.com

RADIN HealthⓇ is focused on developing SaaS products that enhance the efficiency, productivity, and scalability of hospitals, imaging centers and radiology practices. Utilizing artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), Radin Health offers a Cloud-based, Serverless, All-In-One RIS, PACS, Dictation AI®, and Select® Workflow Management Solution. For more information, visit www.radinhealth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/essen-health-care-launches-radin-health-all-in-one-ris-and-pacs-cloud-platform-302760463.html

SOURCE Radin LLC